GlucoTrack (GCTK) Competitors $0.12 +0.04 (+47.23%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends GCTK vs. BTCY, AEMD, CHEK, ICU, POAI, NURO, MHUA, CUTR, STRR, and TTOOShould you be buying GlucoTrack stock or one of its competitors? The main competitors of GlucoTrack include Biotricity (BTCY), Aethlon Medical (AEMD), Check-Cap (CHEK), SeaStar Medical (ICU), Predictive Oncology (POAI), NeuroMetrix (NURO), Meihua International Medical Technologies (MHUA), Cutera (CUTR), Star Equity (STRR), and T2 Biosystems (TTOO). These companies are all part of the "medical equipment" industry. GlucoTrack vs. Biotricity Aethlon Medical Check-Cap SeaStar Medical Predictive Oncology NeuroMetrix Meihua International Medical Technologies Cutera Star Equity T2 Biosystems GlucoTrack (NASDAQ:GCTK) and Biotricity (NASDAQ:BTCY) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends. Is GCTK or BTCY more profitable? GlucoTrack has a net margin of 0.00% compared to Biotricity's net margin of -97.05%. Biotricity's return on equity of 0.00% beat GlucoTrack's return on equity.Company Net Margins Return on Equity Return on Assets GlucoTrackN/A -826.43% -707.26% Biotricity -97.05%N/A -221.26% Do analysts recommend GCTK or BTCY? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GlucoTrack 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Biotricity 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community favor GCTK or BTCY? GlucoTrack and Biotricity both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformGlucoTrackN/AN/ABiotricityOutperform VotesNo VotesUnderperform Votes2100.00% Do institutionals and insiders believe in GCTK or BTCY? 10.9% of GlucoTrack shares are held by institutional investors. Comparatively, 3.9% of Biotricity shares are held by institutional investors. 46.5% of GlucoTrack shares are held by insiders. Comparatively, 10.1% of Biotricity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has preferable earnings and valuation, GCTK or BTCY? GlucoTrack has higher earnings, but lower revenue than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than GlucoTrack, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlucoTrackN/AN/A-$7.10M-$2.83-0.04Biotricity$12.06M0.71-$14.09M-$1.37-0.26 Does the media favor GCTK or BTCY? In the previous week, GlucoTrack had 3 more articles in the media than Biotricity. MarketBeat recorded 4 mentions for GlucoTrack and 1 mentions for Biotricity. GlucoTrack's average media sentiment score of 0.00 equaled Biotricity'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GlucoTrack 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Biotricity 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, GCTK or BTCY? GlucoTrack has a beta of -0.28, suggesting that its share price is 128% less volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500. SummaryGlucoTrack and Biotricity tied by winning 6 of the 12 factors compared between the two stocks. Get GlucoTrack News Delivered to You Automatically Sign up to receive the latest news and ratings for GCTK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GCTK vs. The Competition Export to ExcelMetricGlucoTrackSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.01M$4.83B$5.39B$9.13BDividend YieldN/A52.58%5.37%4.00%P/E Ratio-0.0426.8888.8317.53Price / SalesN/A57.951,282.2680.28Price / CashN/A50.8936.6032.90Price / Book0.167.904.964.69Net Income-$7.10M$13.87M$117.89M$224.57M7 Day Performance2.46%4.15%2.75%3.33%1 Month Performance-56.90%11.37%3.63%5.33%1 Year Performance-89.13%33.39%27.27%22.97% GlucoTrack Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GCTKGlucoTrack0.4112 of 5 stars$0.13+47.2%N/A-92.6%$2.01MN/A-0.045Gap UpHigh Trading VolumeBTCYBiotricityN/A$0.38-12.8%N/A-66.0%$9.21M$12.06M-0.2740Gap DownAEMDAethlon Medical1.8165 of 5 stars$0.64-4.8%$7.00+1,002.4%-65.0%$8.87M$570,000.00-0.2310Analyst ForecastGap DownCHEKCheck-Cap0.292 of 5 stars$1.50-2.0%N/A-41.8%$8.78MN/A-0.5080Analyst ForecastNews CoverageICUSeaStar Medical0.2056 of 5 stars$1.95-2.0%N/A-89.5%$8.70M$68,000.00-0.172POAIPredictive Oncology1.9628 of 5 stars$1.28-5.9%$3.00+134.4%-59.0%$8.53M$1.48M-0.4230NURONeuroMetrix0.479 of 5 stars$4.01+1.0%N/A+35.0%$8.19M$3.77M-0.8720Positive NewsMHUAMeihua International Medical Technologies1.0187 of 5 stars$0.32-1.4%N/A-64.0%$7.97M$94.25M0.00620Positive NewsCUTRCutera1.4118 of 5 stars$0.40-12.7%$3.00+647.4%-82.7%$7.25M$212.37M0.00460Analyst ForecastPositive NewsGap DownHigh Trading VolumeSTRRStar EquityN/A$2.19-1.4%N/A-53.1%$7.05M$45.78M-0.85460Positive NewsTTOOT2 Biosystems1.6236 of 5 stars$0.32flat$5.00+1,462.5%-94.1%$6.73M$7.68M0.00180Analyst ForecastNews CoverageGap Up Related Companies and Tools Related Companies BTCY Alternatives AEMD Alternatives CHEK Alternatives ICU Alternatives POAI Alternatives NURO Alternatives MHUA Alternatives CUTR Alternatives STRR Alternatives TTOO Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GCTK) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlucoTrack, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlucoTrack With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
